awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55457289-661BE802-5E3A-489A-BE5B-8280FF38AC8B
Q55457289-661BE802-5E3A-489A-BE5B-8280FF38AC8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55457289-661BE802-5E3A-489A-BE5B-8280FF38AC8B
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma.
P2860
Q55457289-661BE802-5E3A-489A-BE5B-8280FF38AC8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55457289-661BE802-5E3A-489A-BE5B-8280FF38AC8B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
475f93d2b64f8e324001d469c6f0dd3b15ca6423
P2860
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.